CYCC

Cyclacel Pharmaceuticals
CYCC

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$47.73M
EV
$44.59M
Shares Outstanding
207.34M
Beta
0.16

Wall Street View

Analyst Rating
HOLD
Analyst Target Price
$1.00
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Cyclacel Pharmaceuticals, Inc.

gainify
CYCC

Cyclacel Pharmaceuticals, Inc.

CYCC

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases in the United States, the United Kingdom, and internationally. The company’s lead product includes fadraciclib, ...

Sector

Healthcare

Industry

Biotechnology

CEO

Rombotis, Spiro

Employees

12

IPO Date

2004-03-16

Headquarters

200 Connell Drive, Suite 1500, Berkeley Heights, New Jersey, 07922, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved